RESUMEN
Non-alcoholic fatty liver disease (NAFLD)is a common chronic liver disease. It covers a spectrum of liver diseases that range from hepatic steatosis to steatohepatitis and cirrhosis. The increase in its prevalence is linked to obesity and type 2 diabetes. More evidence shows a relation between overgrowth of gut microbiota with NAFLD and non-alcoholic steatohepatitis (NASH). Recently,many studies indicate that probiotics have very good effcts on improving NAFLD. Probiotics have been seen as a new way of treating NAFLD. But probiotics as treatment of NAFLD still need substantiation through more trials with a larger sample size and with longer-term clinical follow-up. Therefore,the research progress in probiotics treatment on animal experiments and clinical trials in NAFLD is reviewed in order to further understand the role of probiotics treatment,and provide the basis for the treatment of NAFLD.
RESUMEN
OBJECTIVE:To provide direct and high quality pharmaceutical care for outpatients in the department of dermatology.METHODS:Pharmaceutical care department was set up in hospital,the pharmacological knowledge and drug information were kept renewed,and contents,targets and processes of the pharmaceutical care were defined and put into practice.RESULTS&CONCLUSIONS:The practice of pharmaceutical care reduced incidences of drug-induced diseases and medical disputes,while boosted patients'confidence on physicians and pharmacists,and it is conducive to the improvement of physicians'medication level.